Our Blog

Dr. Holzman's Blog

Corneal Cross-linking gets second orphan drug status approval

Dec 8, 2011 @ 02:44 AM — by Jen Weigel
Tagged with: Corneal Cross Linking | Keratoconus | Ectasia | Acos Topcon | Orphan Drug |

Dr. Holzman will be one of the principal investigators in a clinical study for corneal cross-linking which means that we will be able to help patients with keratoconus or post-refractive surgery ectasia all over the Maryland - DC - Virginia region.